Skip to main content
FDA grants new indication to lumateperone (Caplyta) for bipolar depression
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA grants new indication to lumateperone (Caplyta) for bipolar depression
User login
Username
Password
Reset your password
Specialty
Lead
score
Psychiatry
1
1
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Concept
Lead
score
Food and Drug Administration (FDA)
0
0.99
Bipolar Disorder
0
0.82
Depression
0
0.63
Grant
0
0.33
Bipolar Depression
0
1
Xerostomia
0
0.15
Dizziness
0
0.11
Extrapyramidal Symptoms
0
0.11
Metabolism
0
0.11
Mood Disorders
0
0.11
Mouth
0
0.11
Nausea
0
0.11
Psychopharmacology
0
0.11
Dentistry and Oral Health
0
0.1
Schizophrenia
0
0.1